Home
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- KAVA ADVISORY: Health Canada is advising consumers not to use any products containing kava
- Modern Science Confirms Ancient Wisdom!
- Modern Science Confirms Ancient Wisdom!
- "Natural" or "Plant-Derived" Labeling Can Mislead
- CDN: Natural Health Products Report - Update
- NPI Editorial: Are we using Best Practices?
- AHPA Update: Kava Information from the AHPA Executive Committee
- European Commission Proposes Registration Scheme for Herbal Medicine to Avoid Need for Testing
- Statement on Kava in New Zealand
- BICL Discontinues Kava Sales; Health Canada Issues Consumer Warning
- BICL Discontinues Kava Sales; Health Canada Issues Consumer Warning
- Royal DSM N.V. and North China Pharmaceutical Group Corporation announce next steps in their strategic partnership
The companies announced a further detailing agreement confirming the terms of further cooperation including the establishment of two joint ventures in the areas of nutritional products (especially Vitamin C and B12).
- Neptune Technologies & Bioressources Inc. Reports Results for Q1, 2005
Company reports sales and EBITDA reached $1,822,000 and $342,000 respectively for the quarter, with a loss of $390,000 or $0.015 per share.
- Neptune Technologies & Bioressources Inc. Reports Results for Q1, 2005
Company reports sales and EBITDA reached $1,822,000 and $342,000 respectively for the quarter, with a loss of $390,000 or $0.015 per share.
- Nu Skin Enterprises Reports Third Quarter 2005 Results
Company reports revenue of $290.8 million, with net income of $17.7 million and earnings per share of $0.25, compared to income of $20.9 million and earnings per share of $0.29 for the same period prior year; Sales in Mainland China drop 10%.
- Nu Skin Enterprises Reports Third Quarter 2005 Results
Company reports revenue of $290.8 million, with net income of $17.7 million and earnings per share of $0.25, compared to income of $20.9 million and earnings per share of $0.29 for the same period prior year; Sales in Mainland China drop 10%.
- DSM Reports Q3 Results
Netherlands-based DSM has announced FY05 Q3 results, reporting net profit of EUR 151 million, up 25% from Q3 2004.
- DSM Reports Q3 Results
Netherlands-based DSM has announced FY05 Q3 results, reporting net profit of EUR 151 million, up 25% from Q3 2004.
- IFF Reports Third Quarter Results
Company reports sales of $493.1 million, declining 3% in comparison to the prior year with fragrance and flavor sales decreased 1% and 3%. Earnings per share were $.72 compared to $.44 in the prior year quarter.
- IFF Reports Third Quarter Results
Company reports sales of $493.1 million, declining 3% in comparison to the prior year with fragrance and flavor sales decreased 1% and 3%. Earnings per share were $.72 compared to $.44 in the prior year quarter.
- Monsanto, Solae Collaborate to Develop New Soy Proteins
Monsanto and The Solae Company today announced an agreement to develop and market a new line of soy proteins with improved flavor and solubility.
- Monsanto, Solae Collaborate to Develop New Soy Proteins
Monsanto and The Solae Company today announced an agreement to develop and market a new line of soy proteins with improved flavor and solubility.
- Monsanto, Solae Collaborate to Develop New Soy Proteins
Monsanto and The Solae Company today announced an agreement to develop and market a new line of soy proteins with improved flavor and solubility.
- Monsanto, Solae Collaborate to Develop New Soy Proteins
Monsanto and The Solae Company today announced an agreement to develop and market a new line of soy proteins with improved flavor and solubility.
- Advitech Announces Third-Quarter Financial Results
Company reports net loss stood at $1,735,545, or $0.03 per share, compared to a net loss of $921,094, or $0.02 per share for the same period in 2004.
- Advitech Announces Third-Quarter Financial Results
Company reports net loss stood at $1,735,545, or $0.03 per share, compared to a net loss of $921,094, or $0.02 per share for the same period in 2004.
- Archer Daniels Midland Reports First Quarter Results
Company reports earnings of $186 million ($.29 per share) compared to $266 million ($.41 per share) last year, with operating profit increasing 3% to $351 million from $339 million last year.
- Archer Daniels Midland Reports First Quarter Results
Company reports earnings of $186 million ($.29 per share) compared to $266 million ($.41 per share) last year, with operating profit increasing 3% to $351 million from $339 million last year.
- Weider Nutrition International Announces Name Change to Schiff Nutrition International
Company announces its formal name change to Schiff Nutrition International, Inc.; will retain its current New York Stock Exchange symbol: WNI.
- Weider Nutrition International Announces Name Change to Schiff Nutrition International
Company announces its formal name change to Schiff Nutrition International, Inc.; will retain its current New York Stock Exchange symbol: WNI.
- Nutrition 21 Announces Supply & Licensing Agreement with CNS, Inc. for Chromax® Chromium Picolinate Inclusion in FiberChoice® Weight Management Chewable Tablets
Nutrition 21, Inc., (NASDAQ: NXXI) announced a supply & licensing agreement with CNS, Inc, for the exclusive use of Chromax® chromium picolinate as an ingredient in CNS’ newest product FiberChoice Weight Management™ chewable tablets.
- Nutrition 21 Announces Supply & Licensing Agreement with CNS, Inc. for Chromax® Chromium Picolinate Inclusion in FiberChoice® Weight Management Chewable Tablets
Nutrition 21, Inc., (NASDAQ: NXXI) announced a supply & licensing agreement with CNS, Inc, for the exclusive use of Chromax® chromium picolinate as an ingredient in CNS’ newest product FiberChoice Weight Management™ chewable tablets.
- Nutrition 21 Announces Supply & Licensing Agreement with CNS, Inc. for Chromax® Chromium Picolinate Inclusion in FiberChoice® Weight Management Chewable Tablets
Nutrition 21, Inc., (NASDAQ: NXXI) announced a supply & licensing agreement with CNS, Inc, for the exclusive use of Chromax® chromium picolinate as an ingredient in CNS’ newest product FiberChoice Weight Management™ chewable tablets.
- Nutrition 21 Announces Supply & Licensing Agreement with CNS, Inc. for Chromax® Chromium Picolinate Inclusion in FiberChoice® Weight Management Chewable Tablets
Nutrition 21, Inc., (NASDAQ: NXXI) announced a supply & licensing agreement with CNS, Inc, for the exclusive use of Chromax® chromium picolinate as an ingredient in CNS’ newest product FiberChoice Weight Management™ chewable tablets.
- Nutrition 21 Announces Supply & Licensing Agreement with CNS, Inc. for Chromax® Chromium Picolinate Inclusion in FiberChoice® Weight Management Chewable Tablets
Nutrition 21, Inc., (NASDAQ: NXXI) announced a supply & licensing agreement with CNS, Inc, for the exclusive use of Chromax® chromium picolinate as an ingredient in CNS’ newest product FiberChoice Weight Management™ chewable tablets.
- Nutrition 21 Announces Supply & Licensing Agreement with CNS, Inc. for Chromax® Chromium Picolinate Inclusion in FiberChoice® Weight Management Chewable Tablets
Nutrition 21, Inc., (NASDAQ: NXXI) announced a supply & licensing agreement with CNS, Inc, for the exclusive use of Chromax® chromium picolinate as an ingredient in CNS’ newest product FiberChoice Weight Management™ chewable tablets.
- B&D Nutritional Partners With C S Agra
B&D Nutritional Ingredients announces an exclusive marketing agreement with C S Agra of Louisville, KY. B&D Nutritional Ingredients will immediately roll out C S Agra’s proprietary broccoli sprout extract, sgs™-100.
- B&D Nutritional Partners With C S Agra
B&D Nutritional Ingredients announces an exclusive marketing agreement with C S Agra of Louisville, KY. B&D Nutritional Ingredients will immediately roll out C S Agra’s proprietary broccoli sprout extract, sgs™-100.
- B&D Nutritional Partners With C S Agra
B&D Nutritional Ingredients announces an exclusive marketing agreement with C S Agra of Louisville, KY. B&D Nutritional Ingredients will immediately roll out C S Agra’s proprietary broccoli sprout extract, sgs™-100.
- B&D Nutritional Partners With C S Agra
B&D Nutritional Ingredients announces an exclusive marketing agreement with C S Agra of Louisville, KY. B&D Nutritional Ingredients will immediately roll out C S Agra’s proprietary broccoli sprout extract, sgs™-100.
- iSatori Technologies Signs National Exclusive Distribution Agreement With Europa Sports Products
iSatori Technologies has again joined forces with Europa Sports Products, Inc., for national distribution of their entire line of physique and performance enhancement nutritional supplements
- iSatori Technologies Signs National Exclusive Distribution Agreement With Europa Sports Products
iSatori Technologies has again joined forces with Europa Sports Products, Inc., for national distribution of their entire line of physique and performance enhancement nutritional supplements
- iSatori Technologies Signs National Exclusive Distribution Agreement With Europa Sports Products
iSatori Technologies has again joined forces with Europa Sports Products, Inc., for national distribution of their entire line of physique and performance enhancement nutritional supplements
- iSatori Technologies Signs National Exclusive Distribution Agreement With Europa Sports Products
iSatori Technologies has again joined forces with Europa Sports Products, Inc., for national distribution of their entire line of physique and performance enhancement nutritional supplements
- Cyanotech Corporation Reports Second Quarter Fiscal 2006 Financial Results
Company reports sales for FY06 Q2 were 2,517,000, a decrease of 16% relative to sales of $2,998,000 for the same period of the prior fiscal year, with gross profit of $581,000, compared to a gross profit of $1,054,000 prior year.
- Cyanotech Corporation Reports Second Quarter Fiscal 2006 Financial Results
Company reports sales for FY06 Q2 were 2,517,000, a decrease of 16% relative to sales of $2,998,000 for the same period of the prior fiscal year, with gross profit of $581,000, compared to a gross profit of $1,054,000 prior year.
- Mr. Kobi Levy Appointed Executive Vice President and Manager of Frutarom's Global Flavors Division
Company announces that Mr. Kobi Levy has been appointed to the position of Executive Vice President of the global Frutarom Group and Manager of its Global Flavors Division.
- Mr. Kobi Levy Appointed Executive Vice President and Manager of Frutarom's Global Flavors Division
Company announces that Mr. Kobi Levy has been appointed to the position of Executive Vice President of the global Frutarom Group and Manager of its Global Flavors Division.
- Mr. Kobi Levy Appointed Executive Vice President and Manager of Frutarom's Global Flavors Division
Company announces that Mr. Kobi Levy has been appointed to the position of Executive Vice President of the global Frutarom Group and Manager of its Global Flavors Division.
- Mr. Kobi Levy Appointed Executive Vice President and Manager of Frutarom's Global Flavors Division
Company announces that Mr. Kobi Levy has been appointed to the position of Executive Vice President of the global Frutarom Group and Manager of its Global Flavors Division.
- Nutrition 21 Reports First Quarter Fiscal 2006 Results
Company reports revenues of $3.60 million as compared to $2.74 million for the same quarter in fiscal 2005, with gross profit of $3.0 million and an operating loss of $0.8 million, an improvement of $0.4 million when compared to an operating loss of $1.2 million for the same period a year ago. Net loss for the quarter was $1.1 million or ($0.03) per diluted share compared to a net loss of $1.2 million or ($0.03) per diluted share for the same period last year.
- Nutrition 21 Reports First Quarter Fiscal 2006 Results
Company reports revenues of $3.60 million as compared to $2.74 million for the same quarter in fiscal 2005, with gross profit of $3.0 million and an operating loss of $0.8 million, an improvement of $0.4 million when compared to an operating loss of $1.2 million for the same period a year ago. Net loss for the quarter was $1.1 million or ($0.03) per diluted share compared to a net loss of $1.2 million or ($0.03) per diluted share for the same period last year.
- Arcadia Biosciences Receives NIH Research Grant to Develop Soybean Varieties with Desired Levels of Isoflavones
Company will use its proprietary TILLING(R) advanced screening technology to develop soybean plants that, through genetic variation, contain various levels of soy isoflavones, ranging from very high to very low or none at all.
- Arcadia Biosciences Receives NIH Research Grant to Develop Soybean Varieties with Desired Levels of Isoflavones
Company will use its proprietary TILLING(R) advanced screening technology to develop soybean plants that, through genetic variation, contain various levels of soy isoflavones, ranging from very high to very low or none at all.
- TR International Signs Exclusive Distributorship with Shanghai Jiubang for Pyridoxal-5-Phosphate
Company announces that it has acquired the exclusive distribution rights from Shanghai Jiubang for Pyridoxal-5-Phosphate in the U.S. marketplace.
- TR International Signs Exclusive Distributorship with Shanghai Jiubang for Pyridoxal-5-Phosphate
Company announces that it has acquired the exclusive distribution rights from Shanghai Jiubang for Pyridoxal-5-Phosphate in the U.S. marketplace.
- TR International Signs Exclusive Distributorship with Shanghai Jiubang for Pyridoxal-5-Phosphate
Company announces that it has acquired the exclusive distribution rights from Shanghai Jiubang for Pyridoxal-5-Phosphate in the U.S. marketplace.
- TR International Signs Exclusive Distributorship with Shanghai Jiubang for Pyridoxal-5-Phosphate
Company announces that it has acquired the exclusive distribution rights from Shanghai Jiubang for Pyridoxal-5-Phosphate in the U.S. marketplace.
- Blue California Appointed Exclusive Distributor of Water-Soluble Coenzyme Q10
Company has been appointed as the exclusive distributor for a new, water-soluble, coenzyme Q10 product line, CoQ10-WS(TM), manufactured in Japan.
- Blue California Appointed Exclusive Distributor of Water-Soluble Coenzyme Q10
Company has been appointed as the exclusive distributor for a new, water-soluble, coenzyme Q10 product line, CoQ10-WS(TM), manufactured in Japan.
- Blue California Appointed Exclusive Distributor of Water-Soluble Coenzyme Q10
Company has been appointed as the exclusive distributor for a new, water-soluble, coenzyme Q10 product line, CoQ10-WS(TM), manufactured in Japan.
- Blue California Appointed Exclusive Distributor of Water-Soluble Coenzyme Q10
Company has been appointed as the exclusive distributor for a new, water-soluble, coenzyme Q10 product line, CoQ10-WS(TM), manufactured in Japan.
- Blue California Appointed Exclusive Distributor of Water-Soluble Coenzyme Q10
Company has been appointed as the exclusive distributor for a new, water-soluble, coenzyme Q10 product line, CoQ10-WS(TM), manufactured in Japan.
- Blue California Appointed Exclusive Distributor of Water-Soluble Coenzyme Q10
Company has been appointed as the exclusive distributor for a new, water-soluble, coenzyme Q10 product line, CoQ10-WS(TM), manufactured in Japan.
- Blue California Appointed Exclusive Distributor of Water-Soluble Coenzyme Q10
Company has been appointed as the exclusive distributor for a new, water-soluble, coenzyme Q10 product line, CoQ10-WS(TM), manufactured in Japan.
- Nutrition 21 Announces Management Changes
Company announces the resignation of Gail Montgomery as a director and officer of the Company, as well as announcing that Paul Intlekofer has been elected Chief Operating Officer and Chief Financial Officer.
- Nutrition 21 Announces Management Changes
Company announces the resignation of Gail Montgomery as a director and officer of the Company, as well as announcing that Paul Intlekofer has been elected Chief Operating Officer and Chief Financial Officer.
- Nutrition 21 Announces Management Changes
Company announces the resignation of Gail Montgomery as a director and officer of the Company, as well as announcing that Paul Intlekofer has been elected Chief Operating Officer and Chief Financial Officer.
- Nutrition 21 Announces Management Changes
Company announces the resignation of Gail Montgomery as a director and officer of the Company, as well as announcing that Paul Intlekofer has been elected Chief Operating Officer and Chief Financial Officer.
- Nutrition 21 Announces Management Changes
Company announces the resignation of Gail Montgomery as a director and officer of the Company, as well as announcing that Paul Intlekofer has been elected Chief Operating Officer and Chief Financial Officer.
- Wild Oats Markets, Inc. Reports Third Quarter 2005 Results
Company reports a sales increase to $278.5
million, compared to $250.7 million prior year, with a comparable stores increase of 6.1%. Net income was $82,000, or $0.00 per diluted share, compared with a net loss of $7.1 million, or $0.25 per diluted share in the same period last year.
- Wild Oats Markets, Inc. Reports Third Quarter 2005 Results
Company reports a sales increase to $278.5
million, compared to $250.7 million prior year, with a comparable stores increase of 6.1%. Net income was $82,000, or $0.00 per diluted share, compared with a net loss of $7.1 million, or $0.25 per diluted share in the same period last year.
- LycoRed Acquires Buckton Scott Nutrition Business
LycoRed Corp. has acquired the assets and business of Buckton Scott Nutrition, Fairfield, N.J., a subsidiary of Buckton Scott Group.
- LycoRed Acquires Buckton Scott Nutrition Business
LycoRed Corp. has acquired the assets and business of Buckton Scott Nutrition, Fairfield, N.J., a subsidiary of Buckton Scott Group.
- LycoRed Acquires Buckton Scott Nutrition Business
LycoRed Corp. has acquired the assets and business of Buckton Scott Nutrition, Fairfield, N.J., a subsidiary of Buckton Scott Group.
- LycoRed Acquires Buckton Scott Nutrition Business
LycoRed Corp. has acquired the assets and business of Buckton Scott Nutrition, Fairfield, N.J., a subsidiary of Buckton Scott Group.
- LycoRed Acquires Buckton Scott Nutrition Business
LycoRed Corp. has acquired the assets and business of Buckton Scott Nutrition, Fairfield, N.J., a subsidiary of Buckton Scott Group.
- Ideasphere Completes Deal to Acquire Non-Ephedra Metabolife Assets
Company announces that it has closed a transaction to acquire certain assets of Metabolife International, Inc., including the company's core non-ephedra brands, Metabolife Ultra, Metabolife Complete, Metabolife Ultra Caffeine Free and Metabolife Green Tea Formula; a state-of-the-art powder and tablet manufacturing facility located in Orem, Utah; and a distribution center in Memphis.
- Ideasphere Completes Deal to Acquire Non-Ephedra Metabolife Assets
Company announces that it has closed a transaction to acquire certain assets of Metabolife International, Inc., including the company's core non-ephedra brands, Metabolife Ultra, Metabolife Complete, Metabolife Ultra Caffeine Free and Metabolife Green Tea Formula; a state-of-the-art powder and tablet manufacturing facility located in Orem, Utah; and a distribution center in Memphis.
- Martin Bauer North America and Guilin LAYN Natural Ingredients Announce Strategic Distribution Alliance
Company and Guilin LAYN Natural Ingredients (LAYN) have formed a strategic partnership establishing MB North America as the exclusive distributor of LAYN's botanical extract ingredients to manufacturers and marketers in North America.
- Martin Bauer North America and Guilin LAYN Natural Ingredients Announce Strategic Distribution Alliance
Company and Guilin LAYN Natural Ingredients (LAYN) have formed a strategic partnership establishing MB North America as the exclusive distributor of LAYN's botanical extract ingredients to manufacturers and marketers in North America.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Another Reason to Choose Healthy Lifestyle Habits
- Another Reason to Choose Healthy Lifestyle Habits
|
PITTSBURGH, Nov 03, 2005 /PRNewswire via COMTEX/ -- GNC Corporation ("GNC" or the "Company"), the largest global specialty retailer of nutritional supplements, today reported its financial results for the quarter and nine-month period ended September 30, 2005.
The Company reported consolidated revenues of $322.6 million for the third quarter ended September 30, 2005 compared to consolidated revenues of $323.1 million for the same quarter of the prior year, a slight decrease of 0.2%. The Company was able to offset a 32.4% decline in the diet category in our domestic company-owned locations with gains in sales of sports nutrition, herbs and vitamin products. For the third quarter of 2005, same store sales in domestic company-owned stores increased 1.0%. Same store sales in our domestic franchise stores declined 4.7% in the quarter.
EBITDA of $25.5 million for the third quarter ended September 30, 2005, was negatively affected by $1.9 million of unusual costs, including $1.0 million from a legal settlement relating to a third-party product lawsuit and hurricane related losses of $0.9 million. EBITDA for the third quarter of 2004 was $31.6 million which included a $1.3 million charge for a withdrawn securities offering.
Net Income for the third quarter ended September 30, 2005, was $3.2 million compared to $8.5 million for the third quarter of 2004.
Revenue for the nine months ended September 30, 2005, was $992.3 million compared to $1,043.4 million for the same period in 2004. Our domestic same store sales decreased for the first nine months of 2005 by 4.3% in our company-owned locations and 6.5% in our franchise locations. These declines in same store sales resulted in a $51.1 million decrease in total revenue for the nine months ended September 30, 2005. Total sales in our diet category were down 34.6% or $55.2 million in our domestic company-owned locations and were partially offset by gains in the sports nutrition, herbs and vitamin categories.
EBITDA for the nine months ended September 30, 2005 was $84.5 million compared to $115.4 million for the same period in 2004. Net Income for the nine months ended September 30, 2005 was $13.0 million, compared to $39.1 million for the same period in 2004.
For the nine months ended September 30, 2005, the Company generated $34.7 million in cash from operating activities, with ending cash on the consolidated balance sheet of $62.4 million. Additionally, in January 2005, the Company utilized $39.4 million of cash to repay a portion of its Senior Credit Facility in conjunction with the issuance of $150.0 million of 8-5/8% Senior Notes. At September 30, 2005, the Company had $473.9 million of total debt outstanding, with its revolver undrawn.
Bruce Barkus, President and CEO of GNC comments, "Our team continues to focus on the business strategies established at the beginning of the year. We are delighted to announce a 1.0% positive comp in our domestic company-owned stores. The strength of our core business in sports, herbs and vitamins has clearly offset the continuing challenges we face in diet."
As of September 30, 2005, GNC Corporation, headquartered in Pittsburgh, Pennsylvania, operated 2,633 company-owned stores in the U.S. and Canada and had 1,212 domestic franchised locations, 1,114 Rite Aid "store-within-a-store" locations and 822 international franchised locations. GNC is the largest global specialty retailer of nutritional supplements, which includes vitamin, mineral and herbal supplements (VMHS), sports nutrition products, diet and energy products and other wellness products.
This release contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 with respect to our financial condition, results of operations and business that is not historical information. Forward-looking statements can be identified by the use of terminology such as "subject to," "believes," "anticipates," "plans," "expects," "intends," "estimates," "projects," "may," "will," "should," "can," the negatives thereof, variations thereon and similar expressions, or by discussions of strategy. GNC believes there is a reasonable basis for our expectations and beliefs, but they are inherently uncertain, we may not realize our expectations and our beliefs may not prove correct. We undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise. Actual results could differ materially from those described or implied by such forward-looking statements. Factors that may materially affect such forward- looking statements include, among others:
- significant competition in our industry; - unfavorable publicity or consumer perception of our products; - the incurrence of material products liability; - costs of compliance and our failure to comply with governmental regulations; - the failure of our franchisees to conduct their operations profitably and limitations on our ability to terminate or replace under-performing franchisees; - economic, political and other risks associated with our international operations; - our failure to keep pace with the demands of our customers for new products and services; - disruptions in our manufacturing system or losses of manufacturing certifications; - increases in the frequency and severity of insurance claims, particularly for claims for which we are self-insured; - loss or retirement of key members of management; - increases in the cost of borrowings and unavailability of additional debt or equity capital; - the impact of our substantial indebtedness on our operating income and our ability to grow; and - the failure to adequately protect or enforce our intellectual property rights against competitors. |